KYOTO, Japan, March 28, 2016 -- Nidec Corporation (NYSE:NJ) (the “Company”) today announced that it has submitted a shelf registration statement for issuances of corporate bonds in Japan to the Director General of the Kanto Local Finance Bureau of the Ministry of Finance of Japan today, as the existing shelf registration statement for issuances of corporate bonds in Japan will expire on April 4, 2016. The shelf registration is expected to enhance the Company’s flexibility and agility in obtaining funding for the Company and its consolidated subsidiaries as an alternative source of funding in addition to financing through financial institutions and other sources and, through the further diversification of its funding sources, improve the Company’s financial stability.
A brief summary of the shelf registration is described below:
| 1. Planned issue amount: | Up to JPY200 billion |
| 2. Expected effective period: | Two years from the effective date of the shelf registration |
| (expected to be from April 5, 2016 to April 4, 2018) | |
| 3. Planned use of proceeds: | Proceeds from any future issuances are expected to be |
| used for equipment and machinery, for lending and | |
| investing purposes, for redemption and repayment of | |
| short-term and other corporate bonds and other debt, | |
| and for general corporate purposes, including working | |
| capital and other operating expenses. |
| This press release has been prepared for the purpose of announcing the Company’s submission of a shelf registration statement in Japan. This press release is not an offer to sell or the solicitation of an offer to buy securities. The securities have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “1933 Act”). The securities may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements under the 1933 Act. |
Contact: Masahiro Nagayasu General Manager Investor Relations +81-75-935-6140 [email protected]


Samsung Signals Comeback With HBM4 Chips as AI Market Heats Up
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Starlink Plans Satellite Orbit Reconfiguration in 2026 to Boost Space Safety
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms 



